09:36 EDT Candel Therapeutics Inc trading halted, volatility trading pause
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CADL:
- Candel Therapeutics Shows Promising Pancreatic Cancer Trial Results
- Candel Therapeutics announces interim data from Phase 2 trial of CAN-2409
- Candel Therapeutics presents updated data from Phase 1b trial of CAN-3110
- Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma
- Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights